Perioperative cyclooxygenase 2 inhibition to reduce tumor cell adhesion and metastatic potential of circulating tumor cells in non-small cell lung cancer

Journal of Thoracic and Cardiovascular Surgery

Volumn 132, Issue 2, 2006, Pages 297-303

  Backhus, Leah M ^a   Sievers, Eric ^a   Lin, Gloria Y ^a   Castanos, Roberto ^a   Bart, Robert D ^a   Starnes, Vaughn A ^a   Bremner, Ross M ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2; HERMES ANTIGEN; INTERLEUKIN 1;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CIRCULATION; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; ENZYME ASSAY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; MALE; METASTASIS; MOUSE; NONHUMAN; OBSERVER VARIATION; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL; UPREGULATION; WESTERN BLOTTING;

ADENOCARCINOMA; ANIMALS; ANTIGENS, CD44; BLOTTING, WESTERN; CELL ADHESION; CYCLOOXYGENASE 2 INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR MATRIX; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MICE; MICE, SCID; NEOPLASM CIRCULATING CELLS; NEOPLASM METASTASIS; PYRAZOLES; SULFONAMIDES;

EID: 33746228353     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2005.10.060     Document Type: Article

References (37)

1. Yamashita J.I., Kurusu Y., Fujino N., Saisyoji T., and Ogawa M. Detection of circulating tumor cells in patients with non-small cell lung cancer undergoing lobectomy by video-assisted thoracic surgery. a potential hazard for intraoperative hematogenous tumor cell dissemination. J Thorac Cardiovasc Surg 119 (2000) 899-905
2. Rolle A., Gunzel R., Pachmann U., Willen B., Hoeffken K., and Pachmann K. Increase in number of circulating disseminated epithelial cells after surgery for non-small cell lung cancer monitored by MAINTRAC is a predictor for relapse. a preliminary report. World J Surg Oncol 3 (2005) 1477-1489
3. Cristofanilli M., Budd G.T., Ellis M.J., Stopeck A., Matera J., Miller M.C., et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351 (2004) 781-791
4. Dong Q., Huang J., Zhou Y., Li L., Bao G., Feng J., et al. Hematogenous dissemination of lung cancer cells during surgery. quantitative detection by flow cytometry and prognostic significance. Lung Cancer 37 (2002) 293-301
5. Sher Y.P., Shih J.Y., Yang P.C., Roffler S.R., Chu Y.W., Wu C.W., et al. Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes. Clin Cancer Res 11 (2005) 173-179
6. Sienel W., Seen-Hibler R., Mutschler W., Pantel K., and Passlick B. Tumour cells in the tumour draining vein of patients with non-small cell lung cancer. detection rate and clinical significance. Eur J Cardiothorac Surg 23 (2003) 451-456
7. Schneemilch C.E., Schilling T., and Bank U. Effects of general anaesthesia on inflammation. Best Pract Res Clin Anaesthesiol 18 (2004) 493-507
8. Bolla G., and Tuzzato G. Immunologic postoperative competence after laparoscopy versus laparotomy. Surg Endosc 17 (2003) 1247-1250
9. Procopio M.A., Rassias A.J., DeLeo J.A., Pahl J., Hildebrandt L., and Yeager M.P. The in vivo effects of general and epidural anesthesia on human immune function. Anesth Analg 93 (2001) 460-465, 4th contents page
10. Diperna C.A., Bart R.D., Sievers E.M., Ma Y., Starnes V.A., and Bremner R.M. Cyclooxygenase-2 inhibition decreases primary and metastatic tumor burden in a murine model of orthotopic lung adenocarcinoma. J Thorac Cardiovasc Surg 126 (2003) 1129-1133
11. Hida T., Leyton J., Makheja A.N., Ben-Av P., Hla T., Martinez A., et al. Non-small cell lung cancer cycloxygenase activity and proliferation are inhibited by non-steroidal antiinflammatory drugs. Anticancer Res 18 (1998) 775-782
12. Peluffo G.D., Stillitani I., Rodriguez V.A., Diament M.J., and Klein S.M. Reduction of tumor progression and paraneoplastic syndrome development in murine lung adenocarcinoma by nonsteroidal antiinflammatory drugs. Int J Cancer 110 (2004) 825-830
13. Yao M., Lam E.C., Kelly C.R., Zhou W., and Wolfe M.M. Cyclooxygenase-2 selective inhibition with NS-398 suppresses proliferation and invasiveness and delays liver metastasis in colorectal cancer. Br J Cancer 90 (2004) 712-719
14. Masferrer J.L., Leahy K.M., Koki A.T., Zweifel B.S., Settle S.L., Woerner B.M., et al. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res 60 (2000) 1306-1311
15. Dohadwala M., Luo J., Zhu L., Lin Y., Dougherty G.J., Sharma S., et al. Non-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44. J Biol Chem 276 (2001) 20809-20812
16. Bajorath J. Structure and function of CD44. characteristic molecular features and analysis of the hyaluronan binding site. Results Probl Cell Differ 33 (2001) 85-103
17. Isacke C.M., and Yarwood H. The hyaluronan receptor, CD44. Int J Biochem Cell Biol 34 (2002) 718-721
18. Yamada Y., Itano N., Narimatsu H., Kudo T., Hirohashi S., Ochiai A., et al. Receptor for hyaluronan-mediated motility and CD44 expressions in colon cancer assessed by quantitative analysis using real-time reverse transcriptase-polymerase chain reaction. Jpn J Cancer Res 90 (1999) 987-992
19. Cichy J., and Pure E. Cytokines regulate the affinity of soluble CD44 for hyaluronan. FEBS Lett 556 (2004) 69-74
20. Mohamadzadeh M., DeGrendele H., Arizpe H., Estess P., and Siegelman M. Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44/HA-dependent primary adhesion. J Clin Invest 101 (1998) 97-108
21. Fu S.L., Wu Y.L., Zhang Y.P., Qiao M.M., and Chen Y. Anti-cancer effects of COX-2 inhibitors and their correlation with angiogenesis and invasion in gastric cancer. World J Gastroenterol 10 (2004) 1971-1974
22. Dionne R.A., Khan A.A., and Gordon S.M. Analgesia and COX-2 inhibition. Clin Exp Rheumatol 19 6 Suppl 25 (2001) S63-S70
23. Chan Y.W. NSAIDS, COX-2 inhibitors and tramadol. acute postoperative pain management in day-case surgery patients. Singapore Med J 42 (2001) 189-192
24. Cicconetti A., Bartoli A., Ripari F., and Ripari A. COX-2 selective inhibitors. a literature review of analgesic efficacy and safety in oral-maxillofacial surgery. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97 (2004) 139-146
25. Mountain C.F. Staging classification of lung cancer. A critical evaluation. Clin Chest Med 23 (2002) 103-121
26. Turnbull Jr. R.B., Kyle K., Watson F.R., and Spratt J. Cancer of the colon. the influence of the no-touch isolation technic on survival rates. Ann Surg 166 (1967) 420-427
27. Turnbull Jr. R.B. Current concepts in cancer. Cancer of the GI tract: colon, rectum, anus. The no-touch isolation technique of resection. JAMA 231 11 (1975) 1181-1182
28. Kopper L., and Hajdu M. Tumor stem cells. Pathol Oncol Res 10 (2004) 69-73
29. Yamashita J.I., Kurusu Y., Fujino N., Saisyoji T., and Ogawa M. Detection of circulating tumor cells in patients with non-small cell lung cancer undergoing lobectomy by video-assisted thoracic surgery. a potential hazard for intraoperative hematogenous tumor cell dissemination. J Thorac Cardiovasc Surg 119 (2000) 899-905
30. Yamashita J., Matsuo A., Kurusu Y., Saishoji T., Hayashi N., and Ogawa M. Preoperative evidence of circulating tumor cells by means of reverse transcriptase-polymerase chain reaction for carcinoembryonic antigen messenger RNA is an independent predictor of survival in non-small cell lung cancer. a prospective study. J Thorac Cardiovasc Surg 124 (2002) 299-305
31. Lin E., Calvano S.E., and Lowry S.F. Inflammatory cytokines and cell response in surgery. Surgery 127 (2000) 117-126
32. Kulp S.K., Yang Y.T., Hung C.C., Chen K.F., Lai J.P., Tseng P.H., et al. 3-Phosphoinositide-dependent protein kinase-1/Akt signaling represents a major cyclooxygenase-2-independent target for celecoxib in prostate cancer cells. Cancer Res 64 (2004) 1444-1451
33. Song X., Lin H.P., Johnson A.J., Tseng P.H., Yang Y.T., Kulp S.K., et al. Cyclooxygenase-2, player or spectator in cyclooxygenase-2 inhibitor-induced apoptosis in prostate cancer cells. J Natl Cancer Inst 94 (2002) 585-591
34. Zhu J., Song X., Lin H.P., Young D.C., Yan S., Marquez V.E., et al. Using cyclooxygenase-2 inhibitors as molecular platforms to develop a new class of apoptosis-inducing agents. J Natl Cancer Inst 94 (2002) 1745-1757
35. 2 production by non-small cell lung cancer cells regulates matrix metalloproteinase-2 and CD44 in cyclooxygenase-2-dependent invasion. J Biol Chem 277 (2002) 50828-50833
36. Weber G.F., Bronson R.T., Ilagan J., Cantor H., Schmits R., and Mak T.W. Absence of the CD44 gene prevents sarcoma metastasis. Cancer Res 62 (2002) 2281-2286
37. Castelao J.E., Bart III R.D., Diperna C.A., Sievers E.M., and Bremner R.M. Lung cancer and cyclooxygenase-2. Ann Thorac Surg 76 (2003) 1327-1335